Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis | 2 | 2025 | 7 | 1.900 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2021 | 7 | 0.940 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2024 | 4 | 0.930 |
Why?
|
| Cytokines | 2 | 2019 | 60 | 0.720 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 17 | 0.580 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 83 | 0.570 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2016 | 1 | 0.530 |
Why?
|
| Microscopic Polyangiitis | 1 | 2016 | 1 | 0.530 |
Why?
|
| Humans | 9 | 2025 | 4931 | 0.450 |
Why?
|
| Aged | 2 | 2025 | 1188 | 0.280 |
Why?
|
| Female | 4 | 2025 | 2964 | 0.270 |
Why?
|
| Vietnam | 1 | 2025 | 1 | 0.250 |
Why?
|
| Child, Preschool | 1 | 2025 | 177 | 0.240 |
Why?
|
| Pandemics | 1 | 2025 | 65 | 0.230 |
Why?
|
| Systems Analysis | 1 | 2024 | 1 | 0.230 |
Why?
|
| Male | 4 | 2025 | 2620 | 0.230 |
Why?
|
| Child | 1 | 2025 | 336 | 0.230 |
Why?
|
| Young Adult | 1 | 2025 | 382 | 0.220 |
Why?
|
| Adolescent | 1 | 2025 | 569 | 0.210 |
Why?
|
| Macrophages | 2 | 2020 | 20 | 0.210 |
Why?
|
| Middle Aged | 2 | 2025 | 1544 | 0.200 |
Why?
|
| Adult | 1 | 2025 | 1402 | 0.180 |
Why?
|
| Biological Products | 1 | 2021 | 4 | 0.180 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2020 | 19 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2021 | 26 | 0.180 |
Why?
|
| Streptolysins | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hydroxycholesterols | 1 | 2020 | 2 | 0.170 |
Why?
|
| Interferons | 1 | 2020 | 3 | 0.170 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 5 | 0.170 |
Why?
|
| Phagocytes | 1 | 2020 | 2 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2020 | 7 | 0.170 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 16 | 0.170 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 5 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 6 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 154 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2018 | 1 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 23 | 0.150 |
Why?
|
| Mutation | 1 | 2019 | 51 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2018 | 19 | 0.150 |
Why?
|
| Models, Biological | 1 | 2018 | 46 | 0.150 |
Why?
|
| Vasculitis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 45 | 0.130 |
Why?
|
| Animals | 5 | 2020 | 1369 | 0.120 |
Why?
|
| Mice | 4 | 2020 | 555 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2010 | 2 | 0.110 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 2 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 34 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 42 | 0.080 |
Why?
|
| Cell Line | 2 | 2020 | 82 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2008 | 2 | 0.080 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 2 | 0.080 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 5 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 11 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2008 | 32 | 0.080 |
Why?
|
| Bacteria | 2 | 2020 | 8 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2020 | 112 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2019 | 70 | 0.060 |
Why?
|
| Homeostasis | 2 | 2018 | 26 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 196 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 2 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2020 | 7 | 0.040 |
Why?
|
| Intravital Microscopy | 1 | 2020 | 1 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 2 | 0.040 |
Why?
|
| Steroid Hydroxylases | 1 | 2020 | 3 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 9 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 10 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 35 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2020 | 62 | 0.040 |
Why?
|
| Interleukins | 2 | 2010 | 6 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2020 | 164 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 149 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 162 | 0.040 |
Why?
|
| Heredity | 1 | 2019 | 2 | 0.040 |
Why?
|
| Carbon | 1 | 2018 | 2 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 3 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 62 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 44 | 0.040 |
Why?
|
| Risk Factors | 1 | 2021 | 593 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 122 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 3 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 2 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Intestines | 1 | 2010 | 4 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2010 | 3 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 22 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 20 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 43 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2008 | 1 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 2008 | 1 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 64 | 0.020 |
Why?
|